{
    "eid": "2-s2.0-85122424166",
    "title": "Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma",
    "cover-date": "2022-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Surgery",
            "@code": "2746",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oral Surgery",
            "@code": "3504",
            "@abbrev": "DENT"
        },
        {
            "@_fa": "true",
            "$": "Otorhinolaryngology",
            "@code": "2733",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "ameloblastoma",
        "disease-free survival",
        "immunohistochemistry",
        "mutation",
        "proto-oncogene proteins B-raf",
        "survival rate"
    ],
    "authors": [
        "S. Kunmongkolwut",
        "R. Chaisuparat"
    ],
    "citedby-count": 3,
    "ref-count": 40,
    "ref-list": [
        "Global incidence and profile of ameloblastoma: a systematic review and meta-analysis",
        "Ameloblastoma: current etiopathological concepts and management",
        "Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis",
        "The ameloblastoma: primary, curative surgical management",
        "Long-term follow up on recurrence of 305 ameloblastoma cases",
        "Ameloblastoma",
        "Ameloblastoma: a review of recent molecular pathogenetic discoveries",
        "Activating FGFR2-RAS-BRAF mutations in ameloblastoma",
        "High frequency of BRAF V600E mutations in ameloblastoma",
        "Identification of recurrent SMO and BRAF mutations in ameloblastomas",
        "BRAFV600E: implications for carcinogenesis and molecular therapy",
        "High frequency of BRAF V600E mutation in Iranian population ameloblastomas",
        "Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas",
        "Molecular concepts in the pathogenesis of ameloblastoma: implications for therapeutics",
        "Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report",
        "Durable treatment of ameloblastoma with single agent BRAFi Re: clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma",
        "Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation",
        "Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma",
        "BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response",
        "BRAF inhibitor therapy of primary ameloblastoma",
        "WHO classification of head and neck tumours",
        "BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution",
        "BRAF-V600E expression correlates with ameloblastoma aggressiveness",
        "Comparison of stopping rules in forward \u201cstepwise\u201d regression",
        "The impact of confounder selection criteria on effect estimation",
        "Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: an institutional study",
        "Ameloblastoma shows nuclear BAP1 immunoexpression, independently of the BRAF V600E status",
        "Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours",
        "Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas",
        "Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres",
        "High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: clinicopathological significance and correlation with epithelial\u2013mesenchymal transition",
        "The mutational profile of unicystic ameloblastoma",
        "An immunohistochemical and genetic study of BRAF(V600E) mutation in Japanese patients with ameloblastoma",
        "Genetic study of the BRAF gene reveals new variants and high frequency of the V600E mutation among Iranian ameloblastoma patients",
        "BRAF V600E expression in ameloblastomas\u2014a 36-patient cohort from Helsinki University Hospital",
        "Comparison of immunohistochemistry and DNA sequencing for BRAF V600E mutation detection in mandibular ameloblastomas",
        "BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology",
        "Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis",
        "Discrepancy between immunohistochemistry and sequencing for BRAF V600E in odontogenic tumours: comparative analysis of two VE1 antibodies",
        "LGR5+ epithelial tumor stem-like cells generate a 3D-organoid model for ameloblastoma"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}